Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Aulos Bioscience, Inc.
Aulos Bioscience, Inc.
Essen Biotech
Second Life Therapeutics
Ocellaris Pharma, Inc.
University of Arizona
Palleon Pharmaceuticals, Inc.
Cancer Research UK
Marengo Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Klus Pharma Inc.
Revolution Medicines, Inc.
4D pharma plc
Ludwig Institute for Cancer Research
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Celldex Therapeutics